Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. Posted 34.5 Million Yuan Net Loss in First Three Quarters of 2022

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. (杭州天目山药业股份有限公司) (600671.SH) reported a net loss of 34.5 million yuan in the first three quarters of 2022, widening 110.2% year-on-year.

Meanwhile, the company posted 78.3 million yuan in revenue, down 21.6% year-on-year.

At the end of the reporting period, it had 348.9 million yuan in total assets and 317.9 million yuan in total liabilities, with a liability-to-asset ratio of 91.1%.